You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

 

Online download statistics by month:

Online download statistics by month: March 2022 to March 2026

AbstractFullPdf
Mar 2022317325163
Apr 2022363371210
May 2022266273122
Jun 202233733993
Jul 202228128476
Aug 202226926973
Sep 202224424568
Oct 202224425089
Nov 202216917088
Dec 202216116257
Jan 202312612653
Feb 202313213365
Mar 2023141142100
Apr 202314614664
May 2023868861
Jun 2023929361
Jul 2023939368
Aug 202313713755
Sep 202312412558
Oct 202315915986
Nov 202313813865
Dec 2023198199135
Jan 2024152152102
Feb 202412012071
Mar 2024194197199
Apr 202414714985
May 2024136140100
Jun 202413713891
Jul 202427227285
Aug 202419219383
Sep 202413013075
Oct 202413614269
Nov 202414014183
Dec 2024196203106
Jan 202514314477
Feb 2025328331129
Mar 2025213214129
Apr 2025242244116
May 202514815097
Jun 2025848735
Mar 2026110
Total733474153642